Public Comments

September 13, 2022

FAH Submits Comments on CY 2023 OPPS Proposed Rule

September 6, 2022

FAH Submits Comments on CY 23 Physician Fee Schedule Proposed Rule

July 27, 2022

FAH Urges HHS Secretary to Extend PHE Past October

June 17, 2022

FAH Comments on FY 2023 Proposed Rule for IPPS/LTCH PPS

June 7, 2022

Affordability of Employer Coverage for Family Members of Employees

May 31, 2022

FAH Comments on Inpatient Rehabilitation Facility PPS for Federal FY2023 and Updates to IRF Quality Reporting Program

May 31, 2022

FAH Comments on FY 2023 Inpatient Psychiatric Facilities PPS-Rate Update and Quality Reporting-RFI

May 19, 2022

FAH to CMS: OIG Report Highlights Need For Further Action to End MA Plan Abuses and Protect Patients

May 9, 2022

FAH Urges Simplification of SEC Cybersecurity Proposed Rule

April 25, 2022

FAH Letter “Applauds” DHS Efforts on Public Charge Policy

April 22, 2022

FAH Urges OSHA to Align its COVID-19 Rules with CDC

April 19, 2022

FAH Urges Continuity Along With Targeted Changes to DOJ/FTC Merger Guidelines

April 19, 2022

FAH Response to CMS’ Request for Information on Access to Coverage and Care in Medicaid & CHIP

March 28, 2022

FAH, Other Health Care Organizations Urge HHS to Renew the COVID-19 Public Health Emergency

March 18, 2022

FAH, AHA Oppose Physician-Owned Hospital Expansion Request

March 18, 2022

FAH Urges NAAG to Investigate Travel Nurse Staffing Agencies

March 7, 2022

FAH comments recommend improvements to Medicare Advantage for 2023

February 11, 2022

FAH Comments on Proposed National Coverage Determination for Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease

February 11, 2022

FAH Letter Urges HHS to Extend COVID-19 PHE; Outlines Patient, Caregiver Needs

February 3, 2022

FAH Submit Comments on Organ Transplant Programs

January 27, 2022

FAH Comments on Health Exchange Network Adequacy Requirements

January 4, 2022

FAH Submits Comments on CMS COVID-19 Vaccine Mandate Rule

December 20, 2021

FAH Submits Comments to HHS on Withdrawing or Repealing SUNSET Final Rule

December 6, 2021

FAH Files Comments on Surprise Billing Requirements

December 6, 2021

FAH Comments on FDA Drug Compounding Guidance for Hospitals

October 18, 2021

FAH Submits Comments on Surprise Billing Provider Enforcement Proposed Rule

October 11, 2021

FAH Opposes IRF Review Choice Demo in Comments to CMS

September 17, 2021

FAH Comments on CY 2022 Medicare OPPS Proposed Rule

September 13, 2021

FAH Comment on CY22 PFS

September 9, 2021

FAH Urges CMS to Reconsider TennCare III Demo Approval

September 7, 2021

FAH Comments on Surprise Billing Part One

September 2, 2021

FAH Outlines Needed Improvements & Offers Solutions to Prior Authorization, Other MA Issues

August 24, 2021

FAH Letter to Zients on Visa Exit Interview

August 20, 2021

FAH Comment Letter on OSHA COVID-19 Emergency Temporary Standard

August 5, 2021

FAH Offers Recommendations to Cabinet Secretaries for IDR Process in No Surprises Act

July 29, 2021

FAH Submits Comments On Rules for ACA Health Insurance Markets

July 1, 2021

FAH Letter Expressing Concerning Non-Compete Draft Law

July 1, 2021

FAH letter to DOS on Visa Exit Interview

June 28, 2021

FAH Comments on FY 2022 IPPS Proposed Rule

June 15, 2021

FAH Joins in Support of H.R. 3746, the Accountable Care In Rural America Act

June 15, 2021

FAH Letter to Cabinet Secretaries Outlines Recommendations for No Surprises Act Implementation

June 10, 2021

FAH Calls on UnitedHealthcare to “Immediately and Permanently” Rescind Controversial ER Policy

June 7, 2021

FAH Comments on Proposed Rule for FY 2022 Inpatient Rehabilitation Facility Prospective Payment System

June 7, 2021

FAH Comments on Medicare Proposed Rule for FY 2022 Inpatient Psychiatric Facility PPS

May 10, 2021

PDMP stakeholder letter to HHS and DOJ

May 10, 2021

Health Groups ask HHS to Extend Deadline on Relief Funding, Distribute Remaining Money

May 7, 2021

FAH Joins Coalition Letter in Response to HIPAA Proposed Rule

May 5, 2021

FAH Joins Letter on MSSP Quality Overhaul

April 16, 2021

Letter to CMS re: MCIT and Definition of “Reasonable and Necessary” Delay of Effective Date

April 12, 2021

Letter to HHS re: Extending the NextGen ACO Model

April 7, 2021

Prior Authorization Letter to CMS

March 19, 2021

Letter on OMB Revisions to MSA-Rural Statistical Areas

February 22, 2021

FAH to HHS: Ready to Join Biden Administration Efforts to Protect Americans’ Access to Health Care

February 17, 2021

FAH IRF Review Choice Demo Comments to CMS

February 2, 2021

FAH Comments on DEA Proposed Rule on Partially Filling of Prescriptions

January 26, 2021

FAH Comments on “Most Favored Nation” Model

January 11, 2021

CMS Cost Report Comment Letter

January 4, 2021


January 4, 2021

FAH Prior Authorization - API Letter

December 31, 2020

FAH Comments to CMS on Additional Policy and Regulatory Revisions in Response to COVID-19

December 23, 2020

FAH Recommends COVID-19 Waivers for Permanent Policy, Expiration and Future Blanket Status

December 22, 2020

FAH Outlines Health Care Priorities to Biden Transition Team

December 22, 2020

FAH Comments on ACA Exchange Proposed Rule for 2022

December 18, 2020

FAH Submits Comment Letter on Information Blocking Rule

December 4, 2020

Comment Letter, SUNSET Proposed Rule

November 30, 2020

FAH Comments on MA Advance Notice

November 22, 2020

FAH Letter to Biden COVID-19 Task Force

November 2, 2020

FAH CMS CLIA PPACA - Additional Policy and Reg Revisions COVID-19

November 2, 2020

FAH Comments MCIT-Coverage Proposed Rule

October 5, 2020

FAH Opposes CMS Proposal Treating Part C Days in Medicare DSH Calculation

October 5, 2020

FAH Comments on CY21 PFS Proposed Rule

October 5, 2020

FAH Submits Comments on CY 2021 OPPS Proposed Rule

September 16, 2020

FAH Comments on HHS Good Guidance Practices Proposed Rule

August 18, 2020

FAH Response to HWW Stakeholder Call

August 10, 2020

FAH Comment Letter on Grandfathered Plans

July 30, 2020

Higher Education Community Pandemic Liability Letter

July 30, 2020

HALO Surprise Billing Letter to Congress

July 29, 2020

Hospital Letter to CMS on Delaying Repayment of MAAPP

July 13, 2020

FAH Telehealth Taskforce Letter

July 10, 2020

FY2021 IPPS Proposed Rule

July 10, 2020

Waiver Letter to CMS

July 10, 2020

GME Advocacy Coalition Sign On

June 30, 2020

Hospital Associations Group Letter Requesting Delay of Transparency Rule

June 23, 2020

FAH Comments to OIG on Information Blocking and CMPs

June 23, 2020

CMS CJR Extension Comments

May 4, 2020

Azar, Engels HRSA COVID-19 Uninsured

April 23, 2020

HALO Accelerated Payments Letter to CMS, HHS

April 10, 2020

FAH Comments FCC COVID-19 Telehealth Program

April 6, 2020

FAH MA Proposed Rule

April 3, 2020

FAH Letter to Azar

April 1, 2020

FEMA Letter

March 31, 2020

Verma Implementation COVID 033120 with NDMS Attachment Final

March 31, 2020

CARES Act and PHSSEF Letter to Secretary Azar.033020

March 18, 2020

FAH COVID-19 1135 Waiver List to CMS

March 18, 2020

COVID-19 1135 Waiver Letter to CMS

March 15, 2020

HALO Letter to U.S. Surgeon General

March 6, 2020

FAH MA Advance Notice

March 2, 2020

Exchange Benefit and Payment Parameters Proposed Rule Comments 3220

January 31, 2020

FAH Comment Letter on MFAR Proposed Rule

January 30, 2020

FAH Comment Letter on Transparency in Coverage

December 27, 2019

FAH Comments on Tennessee Medicaid "Block Grant"

December 20, 2019

FAH MFAR Comment Period Extension Request

December 20, 2019

FAH AKS Proposed Rule Comments

December 20, 2019

FAH Stark Proposed Rule Comments

December 19, 2019

FAH Comments on FDA CDS Draft Guidance

November 20, 2019

FAH Program Integrity RFI

November 7, 2019

FAH Comments on HRSA Rural Grant Programs RFI

November 4, 2019

Program Integrity - Provider Enrollment

October 16, 2019

DEA Joint Comment Letter: Controlled Substances Quotas

September 27, 2019

CY2020 Physician Fee Schedule Proposed Rule Comments

September 27, 2019

FAH CY2020 OPPS Comment Letter

September 16, 2019

FAH Comment Letter on Proposed Radiation Oncology CMMI Model

September 12, 2019

FAH Comment Letter on Medicaid Access Rule

August 29, 2019

FCC Connected Care Pilot Program Proposed Rule

July 2, 2019

Co-Location Draft Guidance

June 24, 2019

IPPS 2020 FAH Comment Letter

June 17, 2019

FY 2020 IPF Proposed Rule Comment Letter

June 17, 2019

FY 2020 IRF PPS Comment Letter

June 17, 2019

TEFCA 2.0 Letter

June 17, 2019

CMS Ligature Risk Interpretive Guidelines

June 3, 2019

ONC Proposed Rule

June 3, 2019

CMS Proposed Rule - FAH Letter

May 30, 2019

FAH DC Geographic Model RFI Comments

March 29, 2019

FAH responds to Hospital Quality Star Rating on Hospital Compare Public Input Request

March 27, 2019

FAH Comment Letter on Grandfathered Group Health Plans RFI

March 25, 2019

FAH Comment Letter VA Veterans Care Agreements

March 1, 2019

FAH Comments on Medicare Advantage Part D Call Letter

February 19, 2019

FAH Comment Letter 2020 Notice of Benefits and Payment Parameters

January 14, 2019

FAH Responds to FDA’s Request for Comments on the Effects of Drug Shortages

January 14, 2019

FAH Comments on Proposed Medicaid Managed Care Rule

December 21, 2018

FAH Comments on New Section 1332 Guidance

December 21, 2018

FAH Comments on MA and Part D Proposed Rule

December 21, 2018

FAH Comments on Health Reimbursement Arrangements Proposed Rule

December 21, 2018

FAH Comments on International Pricing Index Model ANPRM

December 17, 2018

FAH Comments on Drug Transparency Proposed Rule

December 10, 2018

FAH Supports NLRB Proposed Rule on Joint Employer Standard

December 10, 2018

FAH Comments on Proposed Public Charge Rule Change

December 3, 2018

FAH Comments on Changes to Medicare Appeals Process Proposed Rule

November 19, 2018

FAH Submits Comments on Medicare Burden Reduction Proposed Rule

November 16, 2018

FAH Responds to RFI on IMPACT Act

October 30, 2018

FAH Comments on CMS Hospital Harm Quality Measures for Severe Hyperglycemia and Medication-Related B

October 26, 2018

FAH Responds to OIG Anti-Kickback Statute Request for Information

October 17, 2018

FAH Responds to Request for Information on the Electronic Health Record (EHR) Reporting Program

October 16, 2018

FAH Comments on CMS’s proposed changes to the Medicare Shared Savings Program

October 5, 2018

FAH Comments on FCC Telehealth Pilot Program

September 24, 2018

FAH Comments on CY2019 OPPS Proposed Rule

September 10, 2018

FAH Comments on 2019 Physician Fee Schedule Proposed Rule

August 24, 2018

FAH Stark Law RFI Comments

July 16, 2018

Groups Express Concern to CMS Leader Over Suspension of Risk Adjustment Program

July 16, 2018

FAH Comments on HHS Blueprint

June 26, 2018

FAH Comments on the FY 2019 IRF Prospective Payment System Proposed Rule

June 26, 2018

FAH Comments on FY 2019 Inpatient Psychiatric Facilities (IPF) PPS Proposed Rule

June 25, 2018

FAH Submits Comments to CMS on Proposed FY2019 IPPS & LTCH Payment Rule

May 29, 2018

FAH Comment Letter FDA Compounding Guidance

May 29, 2018

FAH Comment Letter CMMI Direct Provider Contracting Model RFI

May 22, 2018

FAH Comment Letter Medicaid Access Proposed Rule

May 3, 2018

IMPACT Act Medication Profile Measures

April 23, 2018

FAH comment letter_STLD proposed rule

March 6, 2018

FAH Comments on Medicare Advantage Call Letter

March 6, 2018

FAH Comments on Association Health Plans

February 27, 2018

FAH Comments on Quality Measure All-Cause Mortality

February 26, 2018

FAH Comments on OIG Safe Harbor Solicitation

February 20, 2018

MSSP Extreme and Uncontrollable Circumstances IFR

February 18, 2018

FAH Comments on ONC’s Draft Trusted Exchange Framework

February 1, 2018

FAH Comments on FCC Rural Health Care Program

January 29, 2018

CJR Extreme and Uncontrollable Circumstances Policy Comments

January 25, 2018

FAH Comments ASPE Choice and Competition RFI with Enclosure

January 16, 2018

FAH Comments on Medicare Advantage Proposed Rule

January 2, 2018

FAH Comments on Extreme and Uncontrollable Circumstance Policy

December 11, 2017

FAH DRAFT 2019 Letter to Issuers Comments

November 27, 2017

FAH Comments on 2019 Notice of Benefit and Payment Parameters Proposed Rule

November 20, 2017

FAH Comments on CMMI RFI

November 17, 2017

FAH Comment on the Patients Over Paperwork Initiative

October 31, 2017

FAH supports Championing Healthy Kids Act

October 24, 2017

Details Matter: Response to Hospital Drug Pricing Report

October 20, 2017

CSR Coalition Statement

October 16, 2017

FAH Comments on the EPM Cancelation Proposed Rule

October 14, 2017

CSR Coalition Letter

September 27, 2017

FAH Comments on Proposed Methodology Changes to the Hospital Star Ratings Program

September 25, 2017

FAH Comments on Proposed 2018 Home Health Rule

September 23, 2017

Health Care Groups Comment on the Graham-Cassidy Proposal

September 19, 2017

Drug Coalition Letter to House on CREATES

September 18, 2017

Health Care Coalition Sends Letter to Congress Asking for Delay in Medicaid DSH Cuts

September 11, 2017

FAH Comments on 2018 Proposed Hospital Outpatient Prospective Payment

September 11, 2017

FAH Comments on 2018 Proposed Physician Fee Schedule Rule

August 28, 2017

FAH Medicaid DSH Proposed Rule Letter

August 18, 2017

FAH Comments on MACRA 2018 Proposal

July 12, 2017

FAH Responds to Request for Information Regarding Stabilizing Health Insurance Markets

June 26, 2017

FAH Comments on IRF PPS Proposed Rule

June 13, 2017

Attachments to FAH Comments on FY 2018 IPPS Proposed Rule

June 13, 2017

FAH Comments on FY 2018 IPPS Proposed Rule

June 2, 2017

FAH Comments to Labor Secretary on Regulatory Relief Issues

May 17, 2017

FAH Shares Regulatory Relief Recommendations with Administration

April 27, 2017

Coalition Issues Joint Statement on CSR Funding

April 25, 2017

FAH Response to Request for Information in the 2018 Rate Announcement and Final Call Letter

April 25, 2017

FAH Comments on CMS Rule Proposing Delay of Cardiac Bundling Rule

March 3, 2017

FAH Comments on 2018 Medicare Advantage Call Letter

January 3, 2017

FAH Comments on Interim Final OPPS Rule